Novo Nordisk to acquire Cardior Pharmaceuticals to expand cardiovascular portfolio

In a significant move within the pharmaceutical industry, Novo Nordisk has agreed to acquire Cardior Pharmaceuticals for up to 1.025 billion Euros. This strategic acquisition ... Read More